tiprankstipranks
Trending News
More News >
Harvard Bioscience (HBIO)
NASDAQ:HBIO
US Market

Harvard Bioscience (HBIO) Financial Statements

Compare
273 Followers

Harvard Bioscience Financial Overview

Harvard Bioscience's market cap is currently $26.18M. The company's EPS TTM is $0; its P/E ratio is -0.48; Harvard Bioscience is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $0.04. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 94.14M$ 112.25M$ 113.33M$ 118.90M$ 102.10M
Gross Profit$ 54.77M$ 66.07M$ 60.82M$ 67.65M$ 58.04M
Operating Income$ -6.21M$ 1.89M$ -6.93M$ 2.07M$ 221.00K
EBITDA$ -1.47M$ 8.03M$ 944.00K$ 9.02M$ 5.17M
Net Income$ -12.40M$ -3.42M$ -9.52M$ -288.00K$ -7.81M
Balance Sheet
Cash & Short-Term Investments$ 4.11M$ 4.28M$ 4.51M$ 7.82M$ 8.32M
Total Assets$ 126.64M$ 137.37M$ 145.36M$ 162.34M$ 156.25M
Total Debt$ 44.49M$ 42.77M$ 54.24M$ 56.96M$ 57.60M
Net Debt$ 40.39M$ 38.49M$ 49.73M$ 49.14M$ 49.28M
Total Liabilities$ 63.30M$ 64.29M$ 73.14M$ 78.94M$ 79.57M
Stockholders' Equity$ 63.34M$ 73.07M$ 72.22M$ 83.40M$ 76.68M
Cash Flow
Free Cash Flow$ -1.82M$ 11.72M$ -438.00K$ -83.00K$ 8.18M
Operating Cash Flow$ 1.44M$ 14.03M$ 1.15M$ 1.26M$ 9.33M
Investing Cash Flow$ -1.34M$ -1.80M$ -1.59M$ -1.34M$ -1.40M
Financing Cash Flow$ -131.00K$ -12.13M$ -2.84M$ -252.00K$ -7.97M
Currency in USD

Harvard Bioscience Earnings and Revenue History

Harvard Bioscience Debt to Assets

Harvard Bioscience Cash Flow

Harvard Bioscience Forecast EPS vs Actual EPS